JPWO2021202772A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021202772A5 JPWO2021202772A5 JP2022560168A JP2022560168A JPWO2021202772A5 JP WO2021202772 A5 JPWO2021202772 A5 JP WO2021202772A5 JP 2022560168 A JP2022560168 A JP 2022560168A JP 2022560168 A JP2022560168 A JP 2022560168A JP WO2021202772 A5 JPWO2021202772 A5 JP WO2021202772A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- pharmaceutical composition
- nanoparticles
- protein
- cationic lipid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003766P | 2020-04-01 | 2020-04-01 | |
| US63/003,766 | 2020-04-01 | ||
| US202063022999P | 2020-05-11 | 2020-05-11 | |
| US63/022,999 | 2020-05-11 | ||
| US202063128600P | 2020-12-21 | 2020-12-21 | |
| US63/128,600 | 2020-12-21 | ||
| PCT/US2021/025222 WO2021202772A1 (en) | 2020-04-01 | 2021-03-31 | Multilamellar rna nanoparticle vaccine against sars-cov-2 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023520506A JP2023520506A (ja) | 2023-05-17 |
| JPWO2021202772A5 true JPWO2021202772A5 (https=) | 2024-03-22 |
| JP2023520506A5 JP2023520506A5 (https=) | 2024-03-22 |
Family
ID=75625672
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560168A Pending JP2023520506A (ja) | 2020-04-01 | 2021-03-31 | Ｓａｒｓ－ｃｏｖ－２に対する多層ｒｎａナノ粒子ワクチン |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230226169A1 (https=) |
| EP (1) | EP4126030A1 (https=) |
| JP (1) | JP2023520506A (https=) |
| AU (1) | AU2021247163A1 (https=) |
| CA (1) | CA3174187A1 (https=) |
| WO (1) | WO2021202772A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3999034A4 (en) * | 2019-07-19 | 2023-08-23 | University Of Florida Research Foundation, Incorporated | Multilamellar rna nanoparticles |
| EP3901261A1 (en) | 2020-04-22 | 2021-10-27 | BioNTech RNA Pharmaceuticals GmbH | Coronavirus vaccine |
| EP4179328A2 (en) * | 2020-07-10 | 2023-05-17 | Covid Diagnostics Ltd. | Compositions, methods, and systems for detecting immune response |
| US20220042117A1 (en) * | 2020-08-06 | 2022-02-10 | Roche Molecular Systems, Inc. | COMPOSITIONS AND METHODS FOR THE SIMULTANEOUS DETECTION OF INFLUENZA A, INFLUENZA B, AND SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) |
| US20240024466A1 (en) * | 2020-12-07 | 2024-01-25 | Trustees Of Tufts College | Lipidoid compositions and methods of use thereof |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2024010686A2 (en) * | 2022-06-20 | 2024-01-11 | The Trustees Of Columbia University In The City Of New York | Vaccine tissue assays |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| WO2025089649A1 (ko) * | 2023-10-26 | 2025-05-01 | 주식회사 차백신연구소 | 양이온성 리포좀을 포함하는 핵산 전달용 조성물 및 그의 용도 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
| MX342785B (es) | 2009-06-10 | 2016-10-12 | Alnylam Pharmaceuticals Inc | Formulacion mejorada de lipido. |
| US8802863B2 (en) | 2010-05-24 | 2014-08-12 | Sirna Therapeutics, Inc. | Amino alcohol cationic lipids for oligonucleotide delivery |
| US8748667B2 (en) | 2010-06-04 | 2014-06-10 | Sirna Therapeutics, Inc. | Low molecular weight cationic lipids for oligonucleotide delivery |
| US11058762B2 (en) * | 2011-07-06 | 2021-07-13 | Glaxosmithkline Biologicals Sa | Immunogenic compositions and uses thereof |
| US10245229B2 (en) * | 2012-06-08 | 2019-04-02 | Translate Bio, Inc. | Pulmonary delivery of mRNA to non-lung target cells |
| CN107073028A (zh) * | 2013-12-13 | 2017-08-18 | 南洋理工大学 | 多层纳米颗粒及其制作方法和使用方法 |
| CN111630173A (zh) * | 2017-10-19 | 2020-09-04 | 库瑞瓦格股份公司 | 新型人工核酸分子 |
| US10979132B2 (en) * | 2018-08-10 | 2021-04-13 | Qualcomm Incorporated | Organization of inter-relay discovery reference signals |
| EP3999034A4 (en) * | 2019-07-19 | 2023-08-23 | University Of Florida Research Foundation, Incorporated | Multilamellar rna nanoparticles |
| US12194089B2 (en) * | 2020-02-04 | 2025-01-14 | CureVac SE | Coronavirus vaccine |
-
2021
- 2021-03-31 CA CA3174187A patent/CA3174187A1/en active Pending
- 2021-03-31 AU AU2021247163A patent/AU2021247163A1/en active Pending
- 2021-03-31 JP JP2022560168A patent/JP2023520506A/ja active Pending
- 2021-03-31 EP EP21720642.4A patent/EP4126030A1/en active Pending
- 2021-03-31 US US17/914,894 patent/US20230226169A1/en active Pending
- 2021-03-31 WO PCT/US2021/025222 patent/WO2021202772A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220370370A1 (en) | Lipid nanoparticles comprising lipophilic anti-inflammatory agents and methods of use thereof | |
| US7037520B2 (en) | Reversible masking of liposomal complexes for targeted delivery | |
| CN1138533C (zh) | 脂质体 | |
| Purohit et al. | Interaction of cationic partial dendrimers with charged and neutral liposomes | |
| RU2216315C2 (ru) | Способ получения липосом | |
| CN116672316B (zh) | 一种核酸-脂质纳米颗粒冻干制剂及其制备方法 | |
| JP2017536092A5 (https=) | ||
| WO2023186149A1 (zh) | 一种脂质化合物、包含其的组合物及应用 | |
| Rodriguez-Gascon et al. | Vaginal gene therapy | |
| JP2025138644A5 (https=) | ||
| JPWO2021202772A5 (https=) | ||
| JP2014506918A (ja) | 抗腫瘍活性物質を含むリポソーム製剤、その調製のための方法、及び、それを含む医薬組成物 | |
| WO2025218536A1 (zh) | 靶向肺部高效递送核酸的脂质纳米颗粒、吸入式制剂及应用 | |
| JPWO2019209787A5 (https=) | ||
| CN115087437A (zh) | 脂质组合物及其用于将治疗活性剂递送至内皮的用途 | |
| CN118267376A (zh) | 一种核酸递送载体及其制备方法和用途 | |
| Shanmugam et al. | Nanostructured self assembled lipid materials for drug delivery and tissue engineering | |
| Talebi et al. | The emerging applications of niosome as a nanotechnology-based approach in vaccine delivery | |
| WO2024108740A1 (zh) | 适合于肌注给药的核酸-脂质纳米颗粒、制剂及其应用 | |
| JPWO2020002540A5 (https=) | ||
| EP2398463A1 (en) | A method for amphiphilic drug loading in liposomes by ion gradient | |
| US20260077037A1 (en) | Cationic lipid based composition, formulation and use for nucleic acid vaccine delivery and preparation thereof | |
| KR20240107033A (ko) | 양이온성 분자 수송체 및 mRNA의 이온복합체를 포함하는 백신 조성물 | |
| Tavano et al. | Nanovesicular formulations for cancer gene therapy | |
| JPWO2021158996A5 (https=) |